中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
机构
采集方式
内容类型
发表日期
学科主题
筛选

浏览/检索结果: 共19条,第1-10条 帮助

条数/页: 排序方式:
Geriatric Nutritional Risk Index is an effective prognostic predictor for metastatic/recurrent or unresectable esophageal cancer receiving immunotherapy 期刊论文  OAI收割
JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2025, 卷号: 16, 期号: 1, 页码: 22
作者:  
Wang, Bei;  Wang, Zixuan;  Xu, Chuanhai;  Wang, Yueqin;  Gao, Honglan
  |  收藏  |  浏览/下载:1/0  |  提交时间:2025/05/27
Comparison of "framework Shuffling" and "CDR Grafting" in humanization of a PD-1 murine antibody 期刊论文  OAI收割
FRONTIERS IN IMMUNOLOGY, 2024, 卷号: 15, 页码: 16
作者:  
Wang, Yongmei;  Chen, Yi-Li;  Xu, Hui;  Rana, Gul E.;  Tan, Xiaorong
  |  收藏  |  浏览/下载:29/0  |  提交时间:2024/09/26
Tislelizumab in previously treated, locally advanced unresectable/metastatic microsatellite instability-high/ mismatch repair-deficient solid tumors 期刊论文  OAI收割
CHINESE JOURNAL OF CANCER RESEARCH, 2024, 卷号: 36
作者:  
Li, Jian;  Xu, Ye;  Zang, Aimin;  Gao, Yunong;  Gao, Quanli
  |  收藏  |  浏览/下载:14/0  |  提交时间:2024/11/22
Original Research Response to programmed cell death protein 1 antibody in patients with Epstein-Barr virus-associated intrahepatic cholangiocarcinoma 期刊论文  OAI收割
EUROPEAN JOURNAL OF CANCER, 2023, 卷号: 194, 页码: 9
作者:  
He, Wen-Zhuo;  Huang, Yu-Hua;  Hu, Wan-Ming;  Wang, Fang;  Xu, Yu-Xia
  |  收藏  |  浏览/下载:34/0  |  提交时间:2023/12/11
Deep learning for predicting immunotherapeutic efficacy in advanced non-small cell lung cancer patients: a retrospective study combining progression-free survival risk and overall survival risk 期刊论文  OAI收割
TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 页码: 23
作者:  
He, Bing-Xi;  Zhong, Yi-Fan;  Zhu, Yong-Bei;  Deng, Jia-Jun;  Fang, Meng-Jie
  |  收藏  |  浏览/下载:32/0  |  提交时间:2022/06/10
Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China 期刊论文  OAI收割
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021
作者:  
Zhang, Xiangyu;  Zeng, Liang;  Li, Yizhi;  Xu, Qinqin;  Yang, Haiyan
  |  收藏  |  浏览/下载:44/0  |  提交时间:2021/03/15
The safety and efficacy of neoadjuvant PD-1 inhibitor with chemotherapy for locally advanced esophageal squamous cell carcinoma 期刊论文  OAI收割
JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021, 卷号: 12
作者:  
Shen, Dijian;  Chen, Qixun;  Wu, Jie;  Li, Jianqiang;  Tao, Kaiyi
  |  收藏  |  浏览/下载:57/0  |  提交时间:2021/04/26
Safety and efficacy of combination therapy using programmed cell death protein-1/programmed cell death ligand-1 inhibitors and radiotherapy in patients with non-small-cell lung cancer: A systematic review and meta-analysis 期刊论文  OAI收割
CANCER MEDICINE, 2021, 页码: 19
作者:  
Geng, Yichao;  Zhang, Qiuning;  Feng, Shuangwu;  Li, Chengcheng;  Wang, Lina
  |  收藏  |  浏览/下载:33/0  |  提交时间:2021/12/10
PD-1 inhibitor combined with apatinib for advanced gastric or esophagogastric junction cancer: a retrospective study 期刊论文  OAI收割
TRANSLATIONAL CANCER RESEARCH, 2020, 卷号: 9
作者:  
Wei, Qing;  Yuan, Xing;  Li, Jingjing;  Xu, Qi;  Ying, Jieer
  |  收藏  |  浏览/下载:23/0  |  提交时间:2020/11/30
PD-L1 expression levels on tumor cells affect their immunosuppressive activity 期刊论文  OAI收割
ONCOLOGY LETTERS, 2019, 卷号: 18, 期号: 5, 页码: 5399-5407
作者:  
Zheng, Yang;  Fang, You-Chen;  Li, Jing
  |  收藏  |  浏览/下载:33/0  |  提交时间:2020/07/01